Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 14 studies | 32% ± 12% | |
microglial cell | 12 studies | 52% ± 18% | |
oligodendrocyte precursor cell | 9 studies | 33% ± 13% | |
macrophage | 7 studies | 28% ± 13% | |
capillary endothelial cell | 5 studies | 23% ± 8% | |
plasmacytoid dendritic cell | 5 studies | 22% ± 6% | |
pericyte | 4 studies | 19% ± 3% | |
endothelial cell of lymphatic vessel | 4 studies | 22% ± 3% | |
myeloid cell | 3 studies | 26% ± 7% | |
astrocyte | 3 studies | 23% ± 7% | |
oligodendrocyte | 3 studies | 19% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 8 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 5741.19 | 653 / 653 | 100% | 16.81 | 603 / 605 |
ovary | 100% | 5743.69 | 180 / 180 | 99% | 13.52 | 425 / 430 |
brain | 98% | 2423.61 | 2599 / 2642 | 100% | 20.62 | 704 / 705 |
breast | 100% | 4135.91 | 459 / 459 | 98% | 12.77 | 1098 / 1118 |
skin | 98% | 2155.38 | 1767 / 1809 | 100% | 19.96 | 471 / 472 |
lung | 100% | 6061.29 | 578 / 578 | 95% | 9.74 | 1103 / 1155 |
uterus | 100% | 4401.92 | 170 / 170 | 94% | 9.38 | 432 / 459 |
esophagus | 96% | 1964.30 | 1388 / 1445 | 95% | 9.30 | 174 / 183 |
kidney | 100% | 2992.70 | 89 / 89 | 89% | 15.45 | 802 / 901 |
stomach | 97% | 1738.15 | 350 / 359 | 91% | 9.92 | 259 / 286 |
intestine | 99% | 2988.88 | 961 / 966 | 87% | 7.27 | 456 / 527 |
bladder | 100% | 2704.14 | 21 / 21 | 82% | 6.50 | 415 / 504 |
adrenal gland | 100% | 1863.86 | 257 / 258 | 79% | 6.86 | 182 / 230 |
prostate | 100% | 2540.94 | 244 / 245 | 56% | 3.02 | 280 / 502 |
pancreas | 50% | 580.69 | 165 / 328 | 96% | 11.42 | 170 / 178 |
adipose | 100% | 4390.78 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4546.21 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.41 | 29 / 29 |
spleen | 100% | 4122.90 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.02 | 45 / 45 |
heart | 100% | 2756.85 | 859 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 8.80 | 77 / 80 |
peripheral blood | 70% | 3301.86 | 650 / 929 | 0% | 0 | 0 / 0 |
muscle | 69% | 822.67 | 551 / 803 | 0% | 0 | 0 / 0 |
liver | 18% | 175.27 | 41 / 226 | 38% | 2.42 | 155 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046847 | Biological process | filopodium assembly |
GO_0008360 | Biological process | regulation of cell shape |
GO_0001525 | Biological process | angiogenesis |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0030866 | Biological process | cortical actin cytoskeleton organization |
GO_0016477 | Biological process | cell migration |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0051015 | Molecular function | actin filament binding |
GO_0032794 | Molecular function | GTPase activating protein binding |
GO_0031267 | Molecular function | small GTPase binding |
Gene name | FMNL3 |
Protein name | FMNL3 protein Formin like 3 Formin-like protein 3 (Formin homology 2 domain-containing protein 3) (WW domain-binding protein 3) (WBP-3) |
Synonyms | KIAA2014 FRL2 FHOD3 WBP3 |
Description | FUNCTION: Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape and migration. Required for developmental angiogenesis (By similarity). In this process, required for microtubule reorganization and for efficient endothelial cell elongation. In quiescent endothelial cells, triggers rearrangement of the actin cytoskeleton, but does not alter microtubule alignement. . |
Accessions | ENST00000335154.10 [Q8IVF7-3] Q8N4Y7 F8W1F5 F8VYL1 Q8IVF7 ENST00000550488.5 ENST00000550424.1 ENST00000352151.9 [Q8IVF7-2] |